Skip to main content

Orchid Cellmark Awarded Contract by UK Child Maintenance and Enforcement Commission

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark today said that it has been awarded a four-year contract by the UK Child Maintenance and Enforcement Commission to exclusively provide DNA paternity testing.

The company based in Princeton, N.J. has been providing such services to CMEC since 2005 when it was called the Child Support Agency. Orchid Cellmark said that it believes revenue over the life of the award could total £3.6 million ($5.6 million). The contract can be extended for three additional years, the company said.

The testing services are sold under the Cellmark brand in the UK.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.